INTRODUCTION: Portal vein thrombosis (PVT) was once considered a contraindication for liver transplantation (LTx) because of technical difficulties. Though no longer a contraindication, it remains a risk factor. AIM: A study of surgical complications following LTx in patients with and without PVT. PATIENTS AND METHODS: A retrospective review of 1,171 consecutive patients who underwent LTx between June 1995 and June 2007 was performed, and 78 recipients with PVT (study group) were compared with a stratified random sample of 78 contemporous recipients without PVT (control group) for postoperative complications. Both groups were comparable with respect to age, sex, race, and other confounding variables. RESULTS: The rate of primary nonfunction (PNF) in the study and control groups was 9.0% and 1.3%, (p = 0.063), while that of retransplantation was 17.9% and 7.7% (p = 0.055), respectively. The mean donor risk index (DRI) among the patients with and without PNF in the study group was 2.58 +/- 0.44 and 2.08 +/- 0.42, respectively (p = 0.014). A significantly higher number of packed red blood cells and fresh frozen plasma transfusions were observed in study group compared to controls (p = 0.012, 0.007, respectively). CONCLUSION: A higher rate of PNF was related to the complexity of the surgical procedure and the use of donor livers with a high DRI. Higher rates of PNF eventually led to a higher rate of retransplant. A strategy of offering donor livers with a low DRI might be helpful in decreasing the rate of PNF. Further, a PV interposition graft in difficult cases instead of thrombectomy could lead to a lower rethrombosis rate.
INTRODUCTION: Portal vein thrombosis (PVT) was once considered a contraindication for liver transplantation (LTx) because of technical difficulties. Though no longer a contraindication, it remains a risk factor. AIM: A study of surgical complications following LTx in patients with and without PVT. PATIENTS AND METHODS: A retrospective review of 1,171 consecutive patients who underwent LTx between June 1995 and June 2007 was performed, and 78 recipients with PVT (study group) were compared with a stratified random sample of 78 contemporous recipients without PVT (control group) for postoperative complications. Both groups were comparable with respect to age, sex, race, and other confounding variables. RESULTS: The rate of primary nonfunction (PNF) in the study and control groups was 9.0% and 1.3%, (p = 0.063), while that of retransplantation was 17.9% and 7.7% (p = 0.055), respectively. The mean donor risk index (DRI) among the patients with and without PNF in the study group was 2.58 +/- 0.44 and 2.08 +/- 0.42, respectively (p = 0.014). A significantly higher number of packed red blood cells and fresh frozen plasma transfusions were observed in study group compared to controls (p = 0.012, 0.007, respectively). CONCLUSION: A higher rate of PNF was related to the complexity of the surgical procedure and the use of donor livers with a high DRI. Higher rates of PNF eventually led to a higher rate of retransplant. A strategy of offering donor livers with a low DRI might be helpful in decreasing the rate of PNF. Further, a PV interposition graft in difficult cases instead of thrombectomy could lead to a lower rethrombosis rate.
Authors: Ernesto P Molmenti; Thomas W Roodhouse; Hebe Molmenti; Kshama Jaiswal; Ghap Jung; Shigeru Marubashi; Edmund Q Sanchez; Brian Gogel; Marlon F Levy; Robert M Goldstein; Carlos G Fasola; Eric E Elliott; Nevenka Bursac; David Mulligan; Thomas A Gonwa; Goran B Klintmalm Journal: Ann Surg Date: 2002-02 Impact factor: 12.969
Authors: J P Lerut; D Mazza; V van Leeuw; P F Laterre; M Donataccio; J de Ville de Goyet; B Van Beers; P Bourlier; P Goffette; T Puttemans; J B Otte Journal: Transpl Int Date: 1997 Impact factor: 3.782
Authors: K Ohnishi; K Okuda; T Ohtsuki; T Nakayama; Y Hiyama; S Iwama; N Goto; Y Nakajima; N Musha; T Nakashima Journal: Gastroenterology Date: 1984-11 Impact factor: 22.682
Authors: T J Gayowski; I R Marino; H R Doyle; L Echeverri; L Mieles; S Todo; M Wagener; N Singh; V L Yu; J J Fung; T E Starzl Journal: J Surg Res Date: 1996-02-01 Impact factor: 2.192
Authors: A C Stieber; G Zetti; S Todo; A G Tzakis; J J Fung; I Marino; A Casavilla; R R Selby; T E Starzl Journal: Ann Surg Date: 1991-03 Impact factor: 12.969
Authors: Paolo Feltracco; Stefania Barbieri; Umberto Cillo; Giacomo Zanus; Marco Senzolo; Carlo Ori Journal: World J Gastroenterol Date: 2015-07-14 Impact factor: 5.742
Authors: Lisa M McElroy; Amna Daud; Ashley E Davis; Brittany Lapin; Talia Baker; Michael M Abecassis; Josh Levitsky; Jane L Holl; Daniela P Ladner Journal: Am J Surg Date: 2014-07-18 Impact factor: 2.565
Authors: Jonathan G Stine; Curtis K Argo; Shawn J Pelletier; Daniel G Maluf; Patrick G Northup Journal: Transpl Int Date: 2016-10-06 Impact factor: 3.782
Authors: Francesca R Ponziani; Maria A Zocco; Chiara Campanale; Emanuele Rinninella; Annalisa Tortora; Luca Di Maurizio; Giuseppe Bombardieri; Raimondo De Cristofaro; Anna M De Gaetano; Raffaele Landolfi; Antonio Gasbarrini Journal: World J Gastroenterol Date: 2010-01-14 Impact factor: 5.742